These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36761917)

  • 1. The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact.
    Collij LE; Farrar G; Valléz García D; Bader I; Shekari M; Lorenzini L; Pemberton H; Altomare D; Pla S; Loor M; Markiewicz P; Yaqub M; Buckley C; Frisoni GB; Nordberg A; Payoux P; Stephens A; Gismondi R; Visser PJ; Ford L; Schmidt M; Birck C; Georges J; Mett A; Walker Z; Boada M; Drzezga A; Vandenberghe R; Hanseeuw B; Jessen F; Schöll M; Ritchie C; Lopes Alves I; Gispert JD; Barkhof F
    Front Neurol; 2022; 13():1063598. PubMed ID: 36761917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study.
    Lopes Alves I; Collij LE; Altomare D; Frisoni GB; Saint-Aubert L; Payoux P; Kivipelto M; Jessen F; Drzezga A; Leeuwis A; Wink AM; Visser PJ; van Berckel BNM; Scheltens P; Gray KR; Wolz R; Stephens A; Gismondi R; Buckely C; Gispert JD; Schmidt M; Ford L; Ritchie C; Farrar G; Barkhof F; Molinuevo JL;
    Alzheimers Dement; 2020 May; 16(5):750-758. PubMed ID: 32281303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of amyloid load using
    Bullich S; Roé-Vellvé N; Marquié M; Landau SM; Barthel H; Villemagne VL; Sanabria Á; Tartari JP; Sotolongo-Grau O; Doré V; Koglin N; Müller A; Perrotin A; Jovalekic A; De Santi S; Tárraga L; Stephens AW; Rowe CC; Sabri O; Seibyl JP; Boada M
    Alzheimers Res Ther; 2021 Mar; 13(1):67. PubMed ID: 33773598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Flicker L; Bonfill Cosp X
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012884. PubMed ID: 29164602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Description of a European memory clinic cohort undergoing amyloid-PET: The AMYPAD Diagnostic and Patient Management Study.
    Altomare D; Collij L; Caprioglio C; Scheltens P; van Berckel BNM; Alves IL; Berkhof J; de Gier Y; Garibotto V; Moro C; Poitrine L; Delrieu J; Payoux P; Saint-Aubert L; Molinuevo JL; Grau-Rivera O; Gispert JD; Minguillón C; Fauria K; Sanchez MF; Rădoi A; Drzezga A; Jessen F; Escher C; Zeyen P; Nordberg A; Savitcheva I; Jelic V; Walker Z; Lee HY; Lee L; Demonet JF; Plaza Wuthrich S; Gismondi R; Farrar G; Barkhof F; Stephens AW; Frisoni GB;
    Alzheimers Dement; 2023 Mar; 19(3):844-856. PubMed ID: 35715930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMYPAD Diagnostic and Patient Management Study: Rationale and design.
    Frisoni GB; Barkhof F; Altomare D; Berkhof J; Boccardi M; Canzoneri E; Collij L; Drzezga A; Farrar G; Garibotto V; Gismondi R; Gispert JD; Jessen F; Kivipelto M; Lopes Alves I; Molinuevo JL; Nordberg A; Payoux P; Ritchie C; Savicheva I; Scheltens P; Schmidt ME; Schott JM; Stephens A; van Berckel B; Vellas B; Walker Z; Raffa N
    Alzheimers Dement; 2019 Mar; 15(3):388-399. PubMed ID: 30339801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of amyloid PET for future clinical use: a state-of-the-art review.
    Pemberton HG; Collij LE; Heeman F; Bollack A; Shekari M; Salvadó G; Alves IL; Garcia DV; Battle M; Buckley C; Stephens AW; Bullich S; Garibotto V; Barkhof F; Gispert JD; Farrar G;
    Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3508-3528. PubMed ID: 35389071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Flicker L; Bonfill Cosp X
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012883. PubMed ID: 29164600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial.
    Altomare D; Barkhof F; Caprioglio C; Collij LE; Scheltens P; Lopes Alves I; Bouwman F; Berkhof J; van Maurik IS; Garibotto V; Moro C; Delrieu J; Payoux P; Saint-Aubert L; Hitzel A; Molinuevo JL; Grau-Rivera O; Gispert JD; Drzezga A; Jessen F; Zeyen P; Nordberg A; Savitcheva I; Jelic V; Walker Z; Edison P; Demonet JF; Gismondi R; Farrar G; Stephens AW; Frisoni GB;
    JAMA Neurol; 2023 Jun; 80(6):548-557. PubMed ID: 37155177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of tau deposition using
    Bullich S; Mueller A; De Santi S; Koglin N; Krause S; Kaplow J; Kanekiyo M; Roé-Vellvé N; Perrotin A; Jovalekic A; Scott D; Gee M; Stephens A; Irizarry M
    Alzheimers Res Ther; 2022 Jul; 14(1):105. PubMed ID: 35897078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Evaluation of
    Matsuda H; Ito K; Ishii K; Shimosegawa E; Okazawa H; Mishina M; Mizumura S; Ishii K; Okita K; Shigemoto Y; Kato T; Takenaka A; Kaida H; Hanaoka K; Matsunaga K; Hatazawa J; Ikawa M; Tsujikawa T; Morooka M; Ishibashi K; Kameyama M; Yamao T; Miwa K; Ogawa M; Sato N
    Front Neurol; 2020; 11():578753. PubMed ID: 33519667
    [No Abstract]   [Full Text] [Related]  

  • 13. Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer's disease.
    Imabayashi E; Tamamura N; Yamaguchi Y; Kamitaka Y; Sakata M; Ishii K
    Ann Nucl Med; 2022 Oct; 36(10):865-875. PubMed ID: 35821311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.
    Vallabhajosula S
    Semin Nucl Med; 2011 Jul; 41(4):283-99. PubMed ID: 21624562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
    Wilcock D; Jicha G; Blacker D; Albert MS; D'Orazio LM; Elahi FM; Fornage M; Hinman JD; Knoefel J; Kramer J; Kryscio RJ; Lamar M; Moghekar A; Prestopnik J; Ringman JM; Rosenberg G; Sagare A; Satizabal CL; Schneider J; Seshadri S; Sur S; Tracy RP; Yasar S; Williams V; Singh H; Mazina L; Helmer KG; Corriveau RA; Schwab K; Kivisäkk P; Greenberg SM;
    Alzheimers Dement; 2021 Apr; 17(4):704-715. PubMed ID: 33480172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
    Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
    JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of semi-quantitative measures of
    Müller EG; Stokke C; Stokmo HL; Edwin TH; Knapskog AB; Revheim ME
    Quant Imaging Med Surg; 2022 Jan; 12(1):493-509. PubMed ID: 34993096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
    Ben Bouallègue F; Mariano-Goulart D; Payoux P;
    Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood Derived Amyloid Biomarkers for Alzheimer's Disease Prevention.
    Udeh-Momoh C; Zheng B; Sandebring-Matton A; Novak G; Kivipelto M; Jönsson L; Middleton L
    J Prev Alzheimers Dis; 2022; 9(1):12-21. PubMed ID: 35098969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial Physician Experience with [
    Hattori N; Sherwin P; Farrar G
    J Alzheimers Dis Rep; 2020 Jun; 4(1):165-174. PubMed ID: 32715277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.